Addressing sociodemographic disparities in COVID-19 vaccine uptake among youth in Zimbabwe.


Journal

BMJ global health
ISSN: 2059-7908
Titre abrégé: BMJ Glob Health
Pays: England
ID NLM: 101685275

Informations de publication

Date de publication:
07 2023
Historique:
received: 10 03 2023
accepted: 17 06 2023
medline: 7 7 2023
pubmed: 6 7 2023
entrez: 5 7 2023
Statut: ppublish

Résumé

COVID-19 vaccine acceptance research has mostly originated from high-income countries and reasons why youth may not get vaccinated may differ in low-income settings. Understanding vaccination coverage across different population groups and the sociocultural influences in healthcare delivery is important to inform targeted vaccination campaigns. A population-based survey was conducted in 24 communities across three provinces (Harare, Bulawayo and Mashonaland East) in Zimbabwe between October 2021 and June 2022. Youth aged 18-24 years were randomly selected using multistage sampling. Sociodemographic characteristics, COVID-19 vaccination uptake and reasons for non-uptake were collected, and odds of vaccination was investigated using logistic regression. 17 682 youth were recruited in the survey (n=10 742, 60.8% female). The median age of participants was 20 (IQR: 19-22) years. Almost two thirds (n=10 652, 60.2%) reported receiving at least one dose of COVID-19 vaccine. A higher proportion of men than women had been vaccinated (68.9% vs 54.7%), and vaccination prevalence increased with age (<19 years: 57.5%, 20-22: 61.5%, >23: 62.2%). Lack of time to get vaccinated, belief that the vaccine was unsafe and anxiety about side effects (particularly infertility) were the main reasons for not getting vaccinated. Factors associated with vaccination were male sex (OR=1.69, 95% CI 1.58 to 1.80), increasing age (>22 years: OR=1.12, 95% CI 1.04 to 1.21), education level (postsecondary: OR=4.34, 95% CI 3.27 to 5.76) and socioeconomic status (least poor: OR=1.32, 95% CI 1.20 to 1.47). This study found vaccine inequity across age, sex, educational attainment and socioeconomic status among youth. Strategies should address these inequities by understanding concerns and tailoring vaccine campaigns to specific groups.

Identifiants

pubmed: 37407229
pii: bmjgh-2023-012268
doi: 10.1136/bmjgh-2023-012268
pmc: PMC10335587
pii:
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 206316/Z/17/Z
Pays : United Kingdom

Informations de copyright

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Z Gesundh Wiss. 2021 Oct 09;:1-10
pubmed: 34660175
Eur Child Adolesc Psychiatry. 2023 Mar;32(3):537-539
pubmed: 34550459
J Glob Health. 2022 May 14;12:05013
pubmed: 35567586
Vaccine. 2016 Dec 7;34(50):6112-6113
pubmed: 27899197
Eur J Haematol. 2022 Oct;109(4):364-372
pubmed: 35751531
J Relig Health. 2017 Oct;56(5):1683-1691
pubmed: 28631171
Health Promot Perspect. 2022 May 29;12(1):34-36
pubmed: 35854842
Health Policy Plan. 2006 Nov;21(6):459-68
pubmed: 17030551
Vaccines (Basel). 2022 Feb 09;10(2):
pubmed: 35214720
Int J Environ Res Public Health. 2022 Aug 23;19(17):
pubmed: 36078194
J R Soc Med. 2021 Jun;114(6):295-298
pubmed: 34077688
Vaccines (Basel). 2022 Nov 15;10(11):
pubmed: 36423029
Glob Health Res Policy. 2022 Jul 19;7(1):21
pubmed: 35850783
Z Gesundh Wiss. 2022 Jan 07;:1-25
pubmed: 35018277
Sci Rep. 2022 Jul 20;12(1):12435
pubmed: 35859048
PLoS One. 2022 Aug 17;17(8):e0272876
pubmed: 35976969
BMJ. 2021 May 20;373:n1138
pubmed: 34016653
Front Public Health. 2022 Aug 26;10:873596
pubmed: 36091533
J Epidemiol Community Health. 2020 Sep;74(9):683-688
pubmed: 32503892
Contemp Clin Trials. 2022 Apr;115:106700
pubmed: 35149232
N Engl J Med. 2022 Sep 15;387(11):1050-1051
pubmed: 36103425
Rev Med Virol. 2023 Jan;33(1):e2359
pubmed: 35491495
Pan Afr Med J. 2021 Nov 24;40:180
pubmed: 35018213

Auteurs

Leyla Larsson (L)

Biomedical Research and Training Institute, Harare, Zimbabwe llarsson3@outlook.com.
Division of Infectious Diseases and Tropical Medicine, Ludwig Maximilians University Munich, Munchen, Germany.

Chido Dziva Chikwari (C)

Biomedical Research and Training Institute, Harare, Zimbabwe.
Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.

Victoria Simms (V)

Biomedical Research and Training Institute, Harare, Zimbabwe.
Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK.

Mandikudza Tembo (M)

Biomedical Research and Training Institute, Harare, Zimbabwe.
Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK.

Agnes Mahomva (A)

National Response to the COVID-19 Pandemic, Zimbabwe Government Office of the President and Cabinet, Harare, Zimbabwe.

Owen Mugurungi (O)

Ministry of Health and Child Care, Harare, Zimbabwe.

Richard J Hayes (RJ)

Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.

Constance R S Mackworth-Young (CRS)

Biomedical Research and Training Institute, Harare, Zimbabwe.
Department of Global Health and Development, London School of Hygiene and Tropical Medicine, London, UK.

Sarah Bernays (S)

School of Public Health, University of Sydney-Sydney Medical School Nepean, Sydney, New South Wales, Australia.
Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK.

Constancia Mavodza (C)

Biomedical Research and Training Institute, Harare, Zimbabwe.
Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK.

Tinotenda Taruvinga (T)

Biomedical Research and Training Institute, Harare, Zimbabwe.
Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, UK.

Tsitsi Bandason (T)

Biomedical Research and Training Institute, Harare, Zimbabwe.

Ethel Dauya (E)

Biomedical Research and Training Institute, Harare, Zimbabwe.

Rashida Abbas Ferrand (RA)

Biomedical Research and Training Institute, Harare, Zimbabwe.
Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.

Katharina Kranzer (K)

Division of Infectious Diseases and Tropical Medicine, Ludwig Maximilians University Munich, Munchen, Germany.
Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH